Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection

Microbial Pathogenesis

Volumn 36, Issue 5, 2004, Pages 273-285

  Kuo, Chih Feng ^a   Luo, Yueh Hsia ^b   Lin, Hsiu Yueh ^b   Huang, Kuen Jeng ^b   Wu, Jiunn Jong ^b   Lei, Huan Yao ^b   Lin, Ming T ^b   Chuang, Woei Jer ^b   Liu, Ching Chuan ^b   Jin, Ying Tai ^b   Lin, Yee Shin ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacterial dissemination; Histopathology; Streptococcal pyrogenic exotoxin B; Streptococcus pyogenes; Vessel permeability

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIAL TOXIN; EXOTOXIN; STREPTOCOCCAL PYROGENIC EXOTOXIN B; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HISTOPATHOLOGY; INOCULATION; KIDNEY INJURY; LIVER INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN CIRCULATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BACTEREMIA; BACTERIAL PROTEINS; BLOOD UREA NITROGEN; CAPILLARY PERMEABILITY; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; EXOTOXINS; GENE DELETION; GENES, BACTERIAL; KIDNEY; LIVER; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MUTAGENESIS, INSERTIONAL; MUTATION, MISSENSE; PEPTIDE HYDROLASES; SPLEEN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES;

EID: 12144291071     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2004.01.003     Document Type: Article

References (52)

1. Stevens D.L. The flesh-eating bacterium: What's next? J Infect Dis. 179:1999;S366-S374.
2. Stevens D.L. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med. 51:2000;271-288.
3. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 13:2000;470-511.
4. Graham M.R., Smoot L.M., Lei B., Musser J.M. Toward a genome-scale understanding of group A Streptococcus pathogenesis. Curr Opin Microbiol. 4:2001;65-70.
5. Graham M.R., Smoot L.M., Lux Migliaccio C.A., et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci USA. 99:2002;13855-13860.
6. Bisno A.L., Brito M.O., Collins C.M. Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 3:2003;191-200.
7. Talkington D.F., Schwartz B., Black C.M., et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun. 61:1993;3369-3374.
8. Chaussee M.S., Liu J., Stevens D.L., Ferretti J.J. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis. 173:1996;901-908.
9. Ji Y., McLandsborough L., Kondagunta A., Cleary P.P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun. 64:1996;503-510.
10. Sriskandan S., Moyes D., Buttery L.K., et al. Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes. J Infect Dis. 173:1996;1399-1407.
11. Ashbaugh C.D., Warren H.B., Carey V.J., Wessels M.R. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest. 102:1998;550-560.
12. Ashbaugh C.D., Moser T.J., Shearer M.H., White G.L., Kennedy R.C., Wessels M.R. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol. 2:2000;283-292.
13. Hsueh P.R., Wu J.J., Tsai P.J., Liu J.W., Chuang Y.C., Luh K.T. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis. 26:1998;584-589.
14. Unnikrishnan M., Altmann D.M., Proft T., et al. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol. 169:2002;2561-2569.
15. Lei B., DeLeo F.R., Hoe N.P., et al. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med. 7:2001;1298-1305.
16. Lei B., deLeo F.R., Reid S.D., et al. Opsonophagocytosis-inhibiting Mac protein of group A Streptococcus: identification and characteristics of two genetic complexes. Infect Immun. 70:2002;6880-6890.
17. Collin M., Svensson M.D., Sjoholm A.G., Jensenius J.C., Sjobring U., Olsen A. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin- mediated opsonophagocytosis. Infect Immun. 70:2002;6646-6651.
18. Eriksson A., Norgren M. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun. 71:2003;211-217.
19. Holm S.E., Norrby A., Bergholm A.M., Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis. 166:1992;31-37.
20. Eriksson B.K.G., Andersson J., Holm S.E., Norgren M. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis. 180:1999;410-418.
21. Mascini E.M., Jansze M., Schellekens J.F.P., et al. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis. 181:2000;631-638.
22. Kapur V., Maffei J.T., Greer R.S., Li L.L., Adams G.J., Musser J.M. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog. 16:1994;443-450.
23. Kuo C.F., Wu J.J., Lin K.Y., et al. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun. 66:1998;3931-3935.
24. Kapur V., Majesky M.W., Li L.L., Black R.A., Musser J.M. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA. 90:1993;7676-7680.
25. Hytonen J., Haataja S., Gerlach D., Podbielski A., Finne J. The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol Microbiol. 39:2001;512-519.
26. Kapur V., Topouzis S., Majesky M.W., et al. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog. 15:1993;327-346.
27. Matsuka Y.V., Pillai S., Gubba S., Musser J.M., Olmsted S.B. Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity. Infect Immun. 67:1999;4326-4333.
28. Kagawa T.F., Cooney J.C., Baker H.M., et al. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc Natl Acad Sci, USA. 97:2000;2235-2240.
29. Raeder R., Boyle M.D.P. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun. 61:1993;1378-1384.
30. Husmann L.K., Dillehay D.L., Jennings V.M., Scott J.R. Streptococcus pyogenes infection in mice. Microb Pathog. 20:1996;213-224.
31. Shanley T.P., Schrier D., Kapur V., Kehoe M., Musser J.M., Ward P.A. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun. 64:1996;870-877.
32. Lukomski S., Sreevatsan S., Amberg C., et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest. 99:1997;2574-2580.
33. Lukomski S., Burns E.H. Jr., Wyde P.R., et al. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun. 66:1998;771-776.
34. Lukomski S., Montgomery C.A., Rurangirwa J., et al. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun. 67:1999;1779-1788.
35. Ashbaugh C.D., Wessels M.R. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun. 69:2001;6683-6686.
36. Saouda M., Wu W., Conran P., Boyle M.D.P. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis. 184:2001;723-731.
37. Kuo C.F., Wu J.J., Tsai P.J., et al. Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells. Infect Immun. 67:1999;126-130.
38. Tsai P.J., Kuo C.F., Lin K.Y., et al. Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun. 66:1998;1460-1466.
39. Svensson M.D., Scaramuzzino D.A., Sjobring U., Olsen A., Frank C., Bessen D.E. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol. 38:2000;242-253.
40. Wolf B.B., Gibson C.A., Kapur V., Hussaini I.M., Musser J.M., Gonias S.L. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem. 269:1994;30682-30687.
41. Burns E.H. Jr., Marciel A.M., Musser J.M. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun. 64:1996;4744-4750.
42. Cu G.A., Mezzano S., Bannan J.D., Zabriskie J.B. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int. 54:1998;819-826.
43. Parra G., Rodriguez-Iturbe B., Batsford S., et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. 54:1998;509-517.
44. Romero M., Mosquera J., Novo E., Fernandez L., Parra G. Erythrogenic toxin type B and its precursor isolated from nephritogenic streptococci induce leukocyte infiltration in normal rat kidneys. Nephrol Dial Transplant. 14:1999;1867-1874.
45. Kansal R.G., McGeer A., Low D.E., Norrby-Teglund A., Kotb M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 68:2000;6362-6369.
46. Woischnik M., Buttaro B.A., Podbielski A. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci. Microb Pathog. 28:2000;221-226.
47. Chaussee M.S., Ajdic D., Ferretti J.J. The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect Immun. 67:1999;1715-1722.
48. Chaussee M.S., Sylva G.L., Sturdevant D.E., et al. Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun. 70:2002;762-770.
49. Kreikemeyer B., Mclver K.S., Podbielski A. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 11:2003;224-232.
50. Chaussee M.S., Gerlach D., Yu C.E., Ferretti J.J. Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes. Infect Immun. 61:1993;3719-3723.
51. Chen C.Y., Luo S.C., Kuo C.F., et al. Maturation processing and characterization of streptopain. J Biol Chem. 278:2003;17336-17343.
52. Schrager H.M., Rheinwald J.G., Wessels M.R. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest. 98:1996;1954-1958.